The First Affiliated Hospital with Nanjing Medical University: Colorectal Neoplasms trials
The registry lists 19 Colorectal Neoplasms studies with The First Affiliated Hospital with Nanjing Medical University as lead sponsor. 11 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 10No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and mFOLFIRI Regimen as First-Line Treatment for Recurrent or Metastatic Colorectal CancerNot yet recruitingNCT07874438Not applicable
- Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal CancerRecruitingNCT07718490Phase 2
- A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)Not yet recruitingNCT07685236
- Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer (SMARTi-RC01)Not yet recruitingNCT07134101Phase 2
- SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Not yet recruitingNCT06835179Phase 2
- Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver MetastasesNot yet recruitingNCT06504901
- Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute ObstructionNot yet recruitingNCT06394791Phase 1/2
- Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver MetastasesNot yet recruitingNCT06124729
- Medical Tai Chi Exercise Healing in Treating mCRC PatientsRecruitingNCT06104267Not applicable
- Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.RecruitingNCT06060704Phase 2
- Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal CancerRecruitingNCT05493683Phase 2
- Colorectal Cancer Screening in Chinese Rural CommunitiesCompletedNCT07180303Not applicable
- Molecular Characteristics of Early-onset Compared With Late-onset Colorectal CancerCompletedNCT06238193
- Early Lymph Node Metastasis in T1/2 Stage Colorectal Cancer: Molecular and Clinical InsightsCompletedNCT06130644
- Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal CancerStatus unknownNCT04866862Phase 2
- Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal CancerStatus unknownNCT04683965Phase 2
- Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid BiopsyStatus unknownNCT04385316
- Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal CancerWithdrawnNCT03843853Phase 2
- Apatinib in Refractory Colorectal CancerCompletedNCT03190616Phase 2